Trinity Biotech (TRIB) Long-Term Debt Repayments (2009 - 2010)
Trinity Biotech's (TRIB) quarterly Long-Term Debt Repayments came in at -$194000.0 in Q4 2010, down 397.44% year-over-year from $65224.1 in Q4 2009, and up 99.28% quarter-over-quarter from -$27.1 million in Q2 2010.
Powered by 
Analysis
Trinity Biotech (TRIB) Long-Term Debt Repayments (2009 - 2010) Analysis & Trends
Trinity Biotech has disclosed Long-Term Debt Repayments across 2 years of filings, most recently posting -$194000.0 for Q4 2010.
- In Q4 2010, Long-Term Debt Repayments fell 397.44% year-over-year to -$194000.0; the TTM figure through Dec 2010 stood at -$29.8 million (down 450.93% YoY), while the FY2010 annual figure was -$29.8 million, down 451.39% from the prior year.
- Long-Term Debt Repayments came in at -$194000.0 for Q4 2010 at Trinity Biotech, up from -$27.1 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of -$39000.0 in Q4 2009 to a low of -$27.1 million in Q2 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.78 Bn | 27.67 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn | 248,000.00 |
| 3 | Heartflow | 4.11 Bn | 3.74 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.60 Bn | 2.41 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | - |
| 6 | Ceribell | 921.90 Mn | 792.63 Mn | 25.94 Mn | - |
| 7 | QuidelOrtho | 886.88 Mn | 763.48 Mn | - | 19.60 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | - |
| 9 | Prenetics Global | 338.37 Mn | 279.32 Mn | 30.20 Mn | - |
| 10 | Trinity Biotech | 5.83 Mn | 5.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | -194,000.00 |
| Jun 30, 2010 | -27.12 Mn |
| Mar 31, 2010 | -2.44 Mn |
| Dec 31, 2009 | -39,000.00 |
| Sep 30, 2009 | -3.22 Mn |
| Mar 31, 2009 | -2.15 Mn |